Spain Biochip Market Size & Outlook, 2025-2030

The biochip market in Spain is expected to reach a projected revenue of US$ 445.2 million by 2030. A compound annual growth rate of 9.1% is expected of Spain biochip market from 2025 to 2030.
Revenue, 2024 (US$M)
$255.1
Forecast, 2030 (US$M)
$445.2
CAGR, 2025 - 2030
9.1%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain biochip market, 2018-2030 (US$M)

Spain biochip market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain biochip market highlights

  • The Spain biochip market generated a revenue of USD 255.1 million in 2024 and is expected to reach USD 445.2 million by 2030.
  • The Spain market is expected to grow at a CAGR of 9.1% from 2025 to 2030.
  • In terms of segment, dna chips was the largest revenue generating type in 2024.
  • Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.

Biochip market data book summary

Market revenue in 2024USD 255.1 million
Market revenue in 2030USD 445.2 million
Growth rate9.1% (CAGR from 2025 to 2030)
Largest segmentDna chips
Fastest growing segmentLab-on-chip
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays
Key market players worldwideAgilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox

Other key industry trends

  • In terms of revenue, Spain accounted for 1.9% of the global biochip market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany biochip market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 2,052.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biochip Market Companies

Name Profile # Employees HQ Website
Randox View profile 1001-5000 Crumlin, Antrim, United Kingdom, Europe http://www.randox.com
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Standard BioTools Inc View profile 539 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 https://www.standardbio.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

Spain biochip market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.


Dna chips was the largest segment with a revenue share of 43.12% in 2024. Horizon Databook has segmented the Spain biochip market based on dna chips, protein chips, lab-on-chip, tissue arrays, cell arrays covering the revenue growth of each sub-segment from 2018 to 2030.


The country’s supportive healthcare policies & initiatives to increase public awareness and monitor the disease rate are expected to increase the demand for advanced therapeutics in the country. According to the Global Competitiveness 2020 Report, the World Economic Forum placed Spain as the country with the world's best healthcare system. 

Key players in the market are adopting strategies such as collaborations, launch of products, and acquisitions to maintain their position in the market. For instance, in July 2022, one of the startup DNA chip firms in Spain won USD 300,000 from a new fund. This funding was to improve the application of DNA chips in disease progression and diagnostics. 

Moreover, supportive government legislation and favorable policies for research are some of the other factors contributing to market expansion. For instance, in December 2022 two researchers from Spain joined CNIO to lead Proteomics and Confocal Microscopy Units. 

Reasons to subscribe to Spain biochip market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain biochip market databook

  • Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain biochip market, including forecasts for subscribers. This country databook contains high-level insights into Spain biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain biochips market size, by type, 2018-2030 (US$M)

Spain Biochip Market Share, 2024 & 2030 (US$M)

Spain biochips market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online